Sign Up | Log In | What is SocialPicks?

AtriCure Inc. (ATRC) Trade Now » Rate ATRC - Discuss ATRC - Add to Watch List

Sector: Healthcare > Industry: Medical Equipment & Supplies

SocialPicks Sentiment:

N/A

** not enough data to be rated

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate ATRC:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

ATRC Analysis & Videos »

... View All >

ATRC: Bull or Bear?

Worth $6 after latest earnings report + credit facility. ATRC

81%

+89.51%
in 200 days

AtriCure, Inc., a medical device company, engages in the development, manufacture, and sale of cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac tissue.

Highlights earnings report

<> <>

Revenues of $13.7 million – up 1% year over year and up 13% sequentially

Adjusted operating loss of $1.1 million – 71% improvement

First quarter of positive adjusted EBITDA – $0.6 million

Completed $10 million credit facility which includes a $6.5 million term loan

<> EXCLUDE enrollment to be complete...

Continue reading »

By amazing (+60.27% risk: conservative) 05/07/09

Comment

... View All >

People Bullish on ATRC

amazing

Analyst

81%

6 mos ago

johnr

Analyst

N/A

over 2 years ago

People Bearish on ATRC

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	378
2	Gerald Greene	18.14	+70.10%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.30%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
BA	The Boeing Company
RIO	Companhia Vale Do Rio Doce
SIRI	Sirius Satellite Radio Inc
FSLR	First Solar Inc.
GE	General Electric Company
GLD	streetTRACKS Gold

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla
DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla
CERS		BioMed News Bytes: GeoVax, Cerus, Discovery Labs by Mike Havrilla

... more »

StreetInsider.com on ATRC

Form 10-Q AtriCure, Inc. For: Sep 30

Piper Jaffray Upgrades AtriCure (ATRC) to Neutral; DoJ Resolution Clearly a Positive

Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement

Form 8-K AtriCure, Inc. For: Nov 04

Atricure (ATRC) Posts Q3 adj.-Loss of $0.06, Beats by 3c

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About AtriCure Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.